02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
- US Agencies Encourage COVID-19-Related Collaboration - Practical Tips for Information Sharing & D...
Read More >
A recently passed Florida law, Florida Statutes 542.336 seeks to prevent medical providers from usin...
Read More >
This alert serves as a reminder of certain year-end reporting requirements imposed under Section 603...
Read More >
The Florida Minimum Wage Act, which applies to all employees in Florida covered by the federal minim...
Read More >
The U.S. Federal Trade Commission (FTC) and U.S. Department of Justice Antitrust Division (“DOJ” a...
Read More >
The year 2020 was an eventful one in the world of healthcare antitrust. The year began with the anno...
Read More >